VistaGen Therapeutics Ownership | Who Owns VistaGen Therapeutics?
VistaGen Therapeutics Ownership Summary
VistaGen Therapeutics is owned by 33.10% institutional investors, 0.27% insiders, and 66.63% retail investors. Orbimed advisors is the largest institutional shareholder, holding 7.25% of VTGN shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 4.43% of its assets in VistaGen Therapeutics shares.
VTGN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | VistaGen Therapeutics | 33.10% | 0.27% | 66.63% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Orbimed advisors | 3.06M | 7.25% | $1.75M |
| Tcg crossover management | 2.68M | 6.34% | $1.53M |
| Vanguard group | 1.82M | 5.10% | $1.21M |
| Commodore capital lp | 1.57M | 4.93% | $5.59M |
| Stempoint capital lp | 616.75K | 1.46% | $58.19K |
| Acadian asset management | 589.66K | 1.40% | $336.00K |
| Ikarian capital | 519.08K | 1.23% | $296.65K |
| Two sigma investments, lp | 469.62K | 1.11% | $268.39K |
| Geode capital management | 453.39K | 1.07% | $259.17K |
| Blackrock funding, inc. /de | 448.51K | 1.06% | $256.32K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Commodore capital lp | 1.57M | 0.27% | $5.59M |
| Almitas capital | 261.40K | 0.21% | $927.97K |
| Luminus management | 396.05K | 0.14% | $226.34K |
| Verdad advisers, lp | 184.94K | 0.12% | $105.69K |
| Tcg crossover management | 2.68M | 0.04% | $1.53M |
| Adar1 capital management | 113.06K | 0.04% | $401.37K |
| Orbimed advisors | 3.06M | 0.03% | $1.75M |
| Advisorshares investments | 277.11K | 0.03% | $158.37K |
| Ikarian capital | 519.08K | 0.02% | $296.65K |
| Stempoint capital lp | 616.75K | 0.01% | $58.19K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Acadian asset management | 589.66K | 0.00% | 589.66K |
| Two sigma investments, lp | 469.62K | 0.00% | 274.05K |
| Millennium management | 430.40K | 0.00% | 233.36K |
| Vanguard fiduciary trust | 217.70K | - | 217.70K |
| Verdad advisers, lp | 184.94K | 0.12% | 184.94K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Nantahala capital management | - | - | -1.98M |
| Soleus capital management | - | - | -550.00K |
| Sphera funds management | - | - | -447.94K |
| Adar1 capital management | 113.06K | 0.04% | -307.70K |
| Jane street group | 272.81K | - | -254.32K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Acadian asset management | 589.66K | 0.00% | 589.66K | $336.00K |
| Vanguard fiduciary trust | 217.70K | - | 217.70K | $124.52K |
| Verdad advisers, lp | 184.94K | 0.12% | 184.94K | $105.69K |
| Shay capital | 144.45K | 0.01% | 144.45K | $82.55K |
| Simplex trading | 89.65K | - | 89.65K | $51.28M |
Sold Out
| Holder | Change |
|---|---|
| Barclays | -1.00 |
| Sjs investment consulting | -100.00 |
| Bfsg | -1.00K |
| Fny investment advisers | -6.00K |
| Drw securities | -10.00K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 60 | -6.25% | 13,980,911 | 1.67% | 33 | 3.12% | 30 | -14.29% | 10 | -28.57% |
| Dec 31, 2025 | 6 | -90.77% | 2,147,851 | -90.81% | 6 | 0.11% | 3 | -91.18% | 3 | -66.67% |
| Sep 30, 2025 | 15 | -71.70% | 2,473,487 | -84.03% | 7 | 0.33% | 3 | -87.50% | 4 | -63.64% |
| Jun 30, 2025 | 53 | 6.00% | 15,493,303 | -1.24% | 48 | 1.86% | 25 | 78.57% | 10 | -52.38% |
| Mar 31, 2025 | 51 | -16.39% | 15,943,080 | 2.72% | 51 | 2.03% | 15 | -54.55% | 20 | 66.67% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 1.28M | 4.43% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.16M | 2.93% | - |
| Biotech Growth Ord | 808.70K | 2.04% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 413.75K | 1.04% | - |
| AdvisorShares Psychedelics ETF | 383.70K | 0.97% | 5.86K |
| Fidelity Extended Market Index | 267.11K | 0.67% | 26.49K |
| iShares Micro-Cap ETF | 98.43K | 0.25% | - |
| BlackRock Extended Equity Market K | 61.89K | 0.23% | -26.00 |
| A4Investments SICAV SIF ACCI IlanaA2EURH | 60.00K | 0.22% | - |
| DFA US Small Cap I | 74.27K | 0.19% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 07, 2023 | COMMODORE CAPITAL LP | - | Buy | $17.96M |
| Aug 18, 2022 | GIN JERRY B | Buy | $17.87K | |
| Aug 17, 2022 | Adler Reid G. | CHIEF LEGAL OFFICER | Buy | $50.91K |
| Aug 17, 2022 | Singh Shawn | CHIEF EXECUTIVE OFFICER | Buy | $103.20K |
| Jul 12, 2022 | Shah Nimish P | Sell | $53.40K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | - |
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2024 Q4 | - | - |
VTGN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools